Table 1.
Women (n = 447) | Men (n = 484) | |
Age (yr) | 76.0 ± 8.4 | 74.8 ± 8.3* |
Adiposity variables | ||
BMI (kg/m2) | 24.4 ± 3.8 | 25.8 ± 3.2* |
Weight (kg) | 61.4 ± 10.5 | 77.6 ± 11.3* |
Waist (cm) | 79.4 ± 10.2 | 94.1 ± 8.7* |
Total body fat (%) | 28.9 ± 5.9 | 19.9 ± 5.1* |
Fat mass (kg) | 18.2 ± 6.7 | 15.9 ± 6.4* |
Dietary variables | ||
Total calcium (log) | 2.90 ± 0.3 | 2.81 ± 0.2* |
Alcohol intake (g/d) | 7.99 ± 11.6 | 14.3 ± 17.2* |
Biochemical markers | ||
Adiponectin (μg/ml) | 16.28 ± 7.1 | 11.1 ± 5.8* |
BMD (g/cm2) | ||
Midshaft radius | 0.558 ± 0.105 | 0.764 ± 0.104* |
Femoral neck | 0.609 ± 0.104 | 0.737 ± 0.130* |
Total hip | 0.745 ± 0.131 | 0.932 ± 0.154* |
Lumbar spine | 0.861 ± 0.168 | 1.068 ± 0.199* |
Categorical variables | (%) | % |
Exercise ≥3 times/week | 62.0 | 76.9* |
Smoking | ||
Never | 53.4 | 31.5* |
Prior smoker | 38.1 | 60.4* |
Current smoker | 8.6 | 8.1* |
Estrogen use | ||
Never | 39.2 | — |
Prior use | 45.9 | — |
Current use | 15.0 | — |
Thyroid medication use | 24.4 | 6.1* |
Thiazide use | 5.7 | 9.3* |
Type 2 diabetes | 13.9 | 13.2 |
* p < 0.05.